Strabismus

World's Most Influential People in Ophthalmology

Retrieved on: 
четверг, мая 9, 2024
Education, FDA, Bascom Palmer Eye Institute, Genetics, Teaching, Surgeon, Paratriathlon, Neuro-ophthalmology, Leach, Strabismus, Cataract, Knowledge, Bascom H. Palmer, Gedde, Eye, DRS, Retina, Vision science, Quality of life, Publication, Research, Bevacizumab, Artificial intelligence, Suture, Health, M.A, Choroideremia, Medeiros, Vance DeGeneres, University, Retinitis pigmentosa, Epidemiology, American Journal, Power, Patient, Physician, Uveitis, Glaucoma, Nursing

MIAMI, May 9, 2024 /PRNewswire/ -- Fifteen Bascom Palmer Eye Institute physicians were selected for the 2024 Power List, a prestigious selection of the world's 100 most influential people shaping the future of eye care, as published by The Ophthalmologist magazine. Drs. Eduardo C. Alfonso, Kendall Donaldson, Hilda Capó, Janet Davis, Harry Flynn, Anat Galor, Steven Gedde, Ranya Habash, Carol Karp, Jaclyn Kovach, Byron Lam, Felipe Medeiros, Richard Parrish, Philip Rosenfeld, and Sonia Yoo were named to the 2024 Power List. Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.

Key Points: 
  • Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.
  • From cutting-edge treatments to groundbreaking research, these doctors are pushing boundaries and setting new standards in ophthalmology."
  • Alfonso, the holder of the Kathleen and Stanley J. Glaser Chair in Ophthalmology, was also named to the Ophthalmologist Power Lists 2014, 2016, 2018, 2022, and 2023.
  • Holder of the John T. Flynn Chair in Ophthalmology, Hilda Capó, M.D., specializes in pediatric ophthalmology and adult strabismus.

NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform

Retrieved on: 
вторник, мая 7, 2024
Health, FDA, Stem Cells, Research, Science, Pharmaceutical, Biotechnology, NMJ, NIH, Safety, Food, Cell, Animal, Acetylcholine, Spasticity, Botulinum toxin, MLB, Santhanam, Neurotoxin, Brain cell, Strabismus, Biology, Paralysis, Drug development, NCATS, Migraine, Drug discovery, Neuromuscular junction, Pharmaceutical industry

The goal of the effort is to develop an advanced testing platform capable of assessing the potency of the Botulinum Toxin (BoT) without the need for animal testing.

Key Points: 
  • The goal of the effort is to develop an advanced testing platform capable of assessing the potency of the Botulinum Toxin (BoT) without the need for animal testing.
  • Despite its therapeutic benefits, BoT is one of the most potent neurotoxins known to man, necessitating stringent batch testing to ensure consistent potency.
  • By successfully developing a high-throughput, human-based platform, Hesperos endeavors to obviate the need for animal testing in this process while simultaneously enhancing the safety profile of BoT.
  • https://fda.gov
    The mission of National Center for Advancing Translational Sciences (NCATS) at NIH is to turn research observations into health solutions through translational science.

Prevent Blindness Declares May as First-ever Inherited Retinal Disease (IRD) Genetic Testing Awareness Month

Retrieved on: 
среда, апреля 24, 2024
Education, Paratriathlon, University, Blood, Birth defect, Retina, RP, Social media, Diagnosis, Stargardt disease, Stargardt, Marketing, Strabismus, Genetic, Johnson & Johnson, Gene, Spark Therapeutics, Choroid, Research, Visual impairment, Genetic testing, Pediatric ophthalmology, Disease, Visual Science, Patient, Eye, Cone dystrophy, MBA, Vision, Student, Therapy, Organization, IRD, Pharmaceutical industry

CHICAGO, April 24, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has designated May as "Inherited Retinal Disease (IRD) Genetic Testing Awareness Month," expanding its previous IRD and Genetic Testing Awareness Week initiative. The group is providing a variety of tools to promote awareness and education for IRDs and the importance of genetic testing, including a free webinar, expert and patient videos, shareable social media graphics, and fact sheets in English and Spanish. IRD Genetic Testing Awareness Month is supported by funding from Johnson & Johnson, and Spark® Therapeutics.

Key Points: 
  • Prevent Blindness expands IRD and genetic testing awareness initiative to educate patients on various forms of IRDs, and the importance of genetic testing to confirm diagnosis and possible treatments.
  • CHICAGO, April 24, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading nonprofit eye health and safety organization, has designated May as "Inherited Retinal Disease (IRD) Genetic Testing Awareness Month," expanding its previous IRD and Genetic Testing Awareness Week initiative.
  • ET, the National Center for Children's Vision and Eye Health at Prevent Blindness will be hosting the free webinar, " Pathway to Diagnosis: Genetic Testing for Inherited Retinal Diseases ."
  • To register for the "Pathway to Diagnosis: Genetic Testing for Inherited Retinal Diseases" webinar, visit PreventBlindness.org/IRD-webinar-2024.

Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way  

Retrieved on: 
среда, апреля 10, 2024
Consensus, Glaucoma, Conditional sentence, University, Finance, RMB, Risk, Approximation error, Patient, Artificial intelligence, Medical device, National Health Commission, Optometry, Endocrinology, Dementia, Certification, Hyperthyroidism, Ageing, Capital Medical University, Software, MICCAI, Hypertensive retinopathy, Beijing Tongren Hospital, Neurology, Acceleration, Intelligence, Paratriathlon, Hospital, Research, Near-sightedness, Amblyopia, AI, MDR, Strabismus, Skin, AMD, Ranibizumab, Diagnosis, Peking University, Growth, Cardiology, Physical examination, News, Cataract, Diabetic retinopathy, Ophthalmology

In 2023, Airdoc Technology significantly accelerated its commercialization，while most of its peers were still in the experimental stage or early stages of commercialization.

Key Points: 
  • In 2023, Airdoc Technology significantly accelerated its commercialization，while most of its peers were still in the experimental stage or early stages of commercialization.
  • 2) health risk assessment solutions, covering 55 types of lesions, providing chronic disease management and health assessments for healthcare industry.
  • Airdoc Technology practices the use of AI technology to assist in the prevention and control of myopia among teenagers and the development of eye health.
  • In July 2023, Airdoc Technology participated in the formulation of the "Expert Consensus on Assessing the Risk of Cardiovascular Diseases Using Artificial Intelligence Technology Based on Fundus Images."

Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases

Retrieved on: 
среда, апреля 10, 2024
Tsinghua University, OCTA, Alzheimer's disease, Finance, CE, Patient, Artificial intelligence, Adolescence, World's fair, Medical device regulation, Dementia, CNV, Certification, Hyperthyroidism, HK, Partnership, Policy, MICCAI, Safety, Lighting, Optical coherence tomography angiography, Intelligence, Choroidal neovascularization, Journal, Hospital, Research, Near-sightedness, Amblyopia, AI, Insurance, Strabismus, AMD, Gold medal, Diagnosis, Peking University, Conference, Growth, Biomarker, Plaque, News, Bleeding, Google Images, Rehabilitation, Medical device

Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases

Key Points: 
  • Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases
    On March 27, medical artificial intelligence company Airdoc Technology (2251.
  • In 2023, through our SaMDs and health risk assessment solutions, we serviced a total of 6.83 million cases and identified 31,459 significant positive cases.
  • In 2023, Airdoc Medical broadened its reach to include hospitals, grassroots medical institutions such as community clinics, and health examination centers.
  • In June 2023, Airdoc, in collaboration with Tsinghua University's Chang Gung Hospital, developed and validated a new deep learning-based neovascular segmentation model.

New VR Solution to Democratize Ophthalmic Surgical Training: Affordable, Portable and Scalable

Retrieved on: 
пятница, апреля 5, 2024
Orbis, Glaucoma, VR, Learning, Environment, Health, Refractive surgery, Partnership, Paratriathlon, ASCRS, Patient, Cataract, Student, Surgeon, Society, Strabismus, Curriculum, Feedback, Annual general meeting, Ophthalmology, Orbis International, Nursing

BOSTON, April 5, 2024 /PRNewswire/ -- Orbis International and FundamentalVR today launched a new immersive virtual reality (VR) training solution intentionally designed for use in low- and middle-income countries, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The tool is built to support students and residents learning to perform surgery to treat cataracts – the world's leading cause of blindness, despite being treatable with a short operation – ultimately growing the number of skilled care providers and improving outcomes for patients. The tool's affordability, portability and scalability, combined with its targeted functionality, make it a key advancement in ophthalmic surgical education globally and will accelerate Orbis's efforts to build strong and sustainable eye care systems around the world.

Key Points: 
  • Orbis, a global nonprofit, teamed up with FundamentalVR, a technology company dedicated to developing VR surgical training solutions, to create this unique tool.
  • It integrates VR, haptic feedback, cloud assessment data, and off-the-shelf hardware to create a solution for cataract surgical training in resource-limited settings.
  • "We saw a real need that we could meet," says Dr. Hunter Cherwek, Orbis Vice President of Clinical Services and Technologies.
  • Thanks to our partnership with FundamentalVR, we were able to bring a new VR solution to life that makes cataract surgical training accessible no matter where you live."

SightMD New York Welcomes Clearview Eye Surgery to It's Expert Team

Retrieved on: 
четверг, января 25, 2024
Family, Patient, Cataract, United States Army, Blepharoplasty, Health, Contact, Trust, Stony Brook University, Partnership, Retina, Eye, Retinal, Communication, Diabetic retinopathy, PHD, Macular degeneration, Strabismus, Suite, Acquisition, Bachelor of Science, Glaucoma, DSM-IV codes, OD, Gettysburg College, Diagnosis, Physician

HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery. Through this strategic partnership Clearview's practice locations at 1825 Riverside Drive, Suite 1B New York, NY 10034, 1200 Waters Place, Suite 304 Bronx, NY 10461 and 132-15 41st Avenue CC Flushing , NY 11355 will expand SightMD's presence by adding three locations and five providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery.
  • - Dr. John J. Kim, Founder of Clearview Eye Surgery
    "We are excited to welcome Clearview Eye Surgery into the SightMD family.
  • Clearview Eye Surgery is dedicated to providing state of the art, professional and personalized eye care to all of our patients to ensure the best possible outcome.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.

SightMD Welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD

Retrieved on: 
пятница, января 19, 2024
Eye, Patient, Amblyopia, TBI, State university system, Infection, Contact, Diagnosis, Glasses, Yale School of Medicine, Strabismus, Paratriathlon, Allergy, Three-body problem, Brain, OD, Brown University, New York Medical College, Illinois College

HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • Jeremy Liang, OD is a board-certified optometrist providing dilated exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • Brian Berliner, OD is a board certified optometrist who has been practicing and providing eye care since 1983.

Merck Manuals Breaks Down What Parents Need to Know About Strabismus

Retrieved on: 
четверг, ноября 2, 2023
Linda, Osteoporosis, Eye, Strabismus, Loma Linda University, Exotropia, Brain, Child, Esotropia, Amblyopia, Hypertropia, Confusion, Paratriathlon, Parent, Editorial, Telescopic sight, MD

RAHWAY, N.J., Nov. 2, 2023 /PRNewswire/ -- As children grow and develop, some parents may notice that their eyes begin to point in different directions and become misaligned. This condition is known as strabismus, and it's relatively common. About 3% of children have strabismus.

Key Points: 
  • In a new editorial from MerckManuals.com, Leila M. Khazaeni, MD, Loma Linda University School of Medicine, shares what parents need to know about strabismus and some key differences between the condition and amblyopia.
  • There are many different types, and most people know the condition by its more informal names like crossed-eyed or wandering eye.
  • Strabismus can lead to amblyopia, known as lazy eye
    There's often confusion between strabismus and amblyopia .
  • Children should be examined periodically to measure vision and to detect strabismus starting at a few months of age.

Easy Blink Optometry Announces Vision Therapy Services to Address Eye Health

Retrieved on: 
вторник, октября 3, 2023
Strabismus, Learning, Eye, Optometry, Quality of life, Amblyopia, Prescription, Glasses, Motion sickness, Convergence insufficiency, Patient, Health, Dyslexia, Telescopic sight, Health care

Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Easy Blink Optometry, a leading vision therapy service provider in Calgary, Alberta, Canada is proud to unveil vision therapy services to address eye health problems affecting one's daily life.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Easy Blink Optometry, a leading vision therapy service provider in Calgary, Alberta, Canada is proud to unveil vision therapy services to address eye health problems affecting one's daily life.
  • Easy Blink Optometry's range of services includes vision therapy, eye examination, dry eye care, specialty eye care, emergency eye care, lens fitting & eyeglasses, and many more.
  • Easy Blink Optometry's dedication to excellence in providing vision therapy and personalized eye care makes them a leading specialist in vision therapy in Alberta.
  • As a vision therapy specialist in South West Calgary, Easy Blink Optometry ensures accurate eye care diagnoses, personalized optometry treatments, and exceptional patient experience tailored to their unique needs.